Sleep and EEG power spectrum effects of the 5-HT1a antagonist NAN-190 alone and in combination with citalopram

Behavioural Brain Research

Volumn 75, Issue 1-2, 1996, Pages 159-168

  Neckelmann, D ^a   Bjorkum A A ^a   Bjorvatn, B ^a   Ursin, R ^a  

^a UNIVERSITY OF BERGEN   (Norway)

Author keywords

5 HT1a; Delta activity; EEG power spectrum; Modulation; NREM sleep; Rat; REM sleep; Serotonin

Indexed keywords

1 (2 METHOXYPHENYL) 4 (4 PHTHALIMIDOBUTYL)PIPERAZINE; CITALOPRAM;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REM SLEEP;

ANIMALS; BEHAVIOR, ANIMAL; CITALOPRAM; DRUG INTERACTIONS; ELECTROENCEPHALOGRAPHY; MALE; PIPERAZINES; RATS; RATS, WISTAR; SEROTONIN ANTAGONISTS; SEROTONIN UPTAKE INHIBITORS; SLEEP; SLEEP STAGES; SLEEP, REM; SYNAPSES; WAKEFULNESS;

EID: 0029980412     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/0166-4328(96)00204-5     Document Type: Article

References (82)

1. Bel, N. and Artigas, F., Chronic treatment with fluvoxamine increases extracellular serotonin in frontal cortex but not in raphe nuclei, Synapse, 15 (1993) 243-245.
2. Berge, O.-G., Post, C. and Archer, T., The behavioural pharmacology of serotonin in the pain processes. In P. Bevan, A.R. Cools and T. Archer (Eds.) Behavioural Pharmacology of 5-HT, Lawrence Earlbaum Associates Inc, New York, 1989, pp. 301-319.
3. 1A antagonist (-)-alprenolol fails to modify sleep or zimeldine-induced sleep-waking effects in rats, Pharmacol. Biochem. Behav., 42 (1992) 49-56.
4. 2 antagonist, on waking and sleep stages in rats, Behav. Brain Res., 40 (1990) 239-246.
5. 1B agonist, CGS 12066B, on sleep/waking stages and EEG power spectrum in rats, J. Sleep Res., 3 (1994) 97-105.
6. BMDP Statistical Software, Version 7.0, University of California Press, Berkeley, CA, 1993.
7. 2 receptors in nucleus prepositus hypoglossi, J. Neurosci., 14 (1994) 2428-2434.
8. Borbely, A.A., Trachsel, L. and Tobler, I., Effect of ritanserin on sleep stages and sleep EEG in the rat, Eur. J. Pharmacol., 156 (1988) 275-278.
9. Cespuglio, R., Faradji, H., Gomez, M. and Jouvet, M., Single unit recordings in the nuclei raphe dorsalis and magnus during the sleep-waking cycle of semi-chronic prepared cats, Neurosci. Lett., 24 (1981) 133-138.
10. Chaput, Y., De Montigny, C. and Blier, P., Effects of a selective 5-HT reuptake blocker, citalopram, on the sensitivity of 5-HT autoreceptors: electrophysiological studies in the rat brain, Naunyn-Schmiedeberg's Arch. Pharmacol., 333 (1986) 342-348.
11. 1A receptor antagonist NAN-190 on rat brain serotonergic transmission, Eur. J. Pharmacol., 204 (1991) 71-77.
12. 1A -agonists on the sleep-wakefulness cycle in rats. In W.P. Koella, F. Obál, H. Schulz and P. Visser (Eds.) Sleep'86: Proceedings of the 8th European Congress on Sleep Research, Gustav-Fisher-Verlag, Stuttgart, 1988, pp. 346-348.
13. 2 receptors could be primarily involved in the regulation of slow-wave sleep in the rat, Eur. J. Pharmacol., 137 (1987) 145-146.
14. 2 receptors in the regulation of sleep and wakefulness in the rat, Psychopharmacology, 97 (1989) 436-442.
15. Edgar, D.M., Miller, J.D., Presser, R.A. and Dean, R.R., Serotonin and the mammalian circadian system. 2 Phase-shifting rat behavioral rhythms with serotonergic agonists, J. Biol. Rhythms, 8 (1993) 17-31.
16. 1A serotonin ligands, J. Med. Chem., 31 (1988) 1968-1971.
17. 1A agonist 8-hydroxy-2-(di-n-propyl-amino)tetralin (8-OH-DPAT), Eur. J. Pharmacol., 154 (1988) 339-341.
18. Green, A.R., 5-HT-mediated behaviour; animal studies, Neuropharmacology, 23 (1984) 1521-1528.
19. 1A receptor antagonists NAN-190 and BMY 7378 are partial agonists in the rat dorsal raphe nucleus in vitro, Eur. J. Pharmacol., 211 (1992) 211-219
20. Hilakivi, I., Kovala, T., Leppävuori, A. and Shvaloff, A., Effects of serotonin and noradrenaline uptake blockers on wakefulness and sleep in cats, Pharmacol. Toxicol., 60 (1987) 161-166.
21. Hilakivi, I., Leppavuori, A. and Putkonen, P.T.S., Prazosin increases paradoxical sleep, Eur. J. Pharmacol., 65 (1980) 417-420.
22. Hilakivi, I. and Leppävuori, A., Effects of methoxamine, and alpha-1 adrenoceptor agonist, and prazosin, an alpha-1 antagonist, on the stages of the sleep-waking cycle in the cat, Acta Physiol. Scand., 120 (1984) 363-372.
23. Hindle, A.T., Recent developements in the physiology and pharmacology of 5-hydroxytryptamine, Br. J. Anaesthesiol., 73 (1994) 395-407.
24. 1A autoreceptor blockade potentiates the ability of the 5-HT reuptake inhibitor citalopram to increase nerve terminal output of 5-HT invivo - A microdialysis study, J. Neurochem., 60 (1993) 776-779.
25. Hjorth, S., Carlsson, A., Lindberg, P., Sanchez, D., Wikstrøm, M., Arveidsson, L.E., Hacksell, U. and Nilsson, J.L.G., 8-Hydroxy-2-(di-n-propylamino)tetralin, 8-OH-DPAT, a potent and selective simplified ergot congener with central 5-HT receptor stimulating activity, J. Neural Transm., 55 (1982) 169-188.
26. 1A receptors: behavioural and in vivo brain microdialysis studies, Life Sci., 46 (1990) 955-963.
27. Hodgkiss, J.P., Dawson. I.M. and Kelly, J.S., An intracellular study of the action of NAN-190 on neurons in the dorsal raphe nucleus of the rat, Brain Res., 576 (1992) 157-161.
28. Hyttel, J., Special topic - citalopram; basic and clinical studies, Prog. Neuro-Psychopharmacol. Biol. Psychiatry, 6 (1982) 275-336.
29. 2 antagonist increases human slow wave sleep, Brain Res., 378 (1986) 164-168.
30. Invernizzi, R., Belli, S. and Samanin, R., Citalopram's ability to increase the extracellular concentrations of serotonin in the dorsal raphe prevents the drug's effect in the frontal cortex, Brain Res., 584 (1992) 322-324.
31. Jacobs, B.L. and Azmitia, E.C., Structure and function of the brain serotonin system, Physiol. Rev., 72 (1992) 165-229.
32. Jouvet, M., Biogenic amines and the states of sleep, Science, 163 (1969) 32-41.
33. Khateb, A., Fort, P., Alonso, A., Jones, B.E. and Mühlethaler, M., Pharmacological and immunohistochemical evidence for serotonergic modulation of cholinergic nucleus basalis neurons, Eur. J. Neurosci., 5 (1993) 541-547.
34. Khateb, A., Mühlethaler, M., Alonso, A., Serafin, M., Mainville, L. and Jones, B.E., Cholinergic nucleus basalis neurons display the capacity for rhythmic bursting activity mediated by low-threshold calcium spikes. Neuroscience, 51 (1992) 489-494.
35. Koella, W.P., Feldstein, A. and Czicman, J.S., The effect of parachlorophenylalanine on the sleep of cats, Electroencephalogr. Clin. Neurophysiol., 25 (1968) 481-490.
36. Le Bars, D., Serotonin and pain. In N.N. Osborne and M. Hamon (Eds.) Neuronal Serotonin, John Wiley & Sons, Chichester, 1988, pp. 171-229.
37. 1A ligands of sleep, J. Sleep Res., 3 (1994) 142 (Abstract)
38. Leonard, C.S. and Llinás, R.R., Serotonergic and cholinergic inhibition of mesopontine cholinergic neurons controlling REM sleep - an in vitro electrophysiological study, Neuroscience, 59 (1994) 309-330.
39. Luebke, J.I., Greene, R.W., Semba, K., Kamondi, A., McCarley, R.W. and Reiner, P.B., Serotonin hyperpolarizes cholinergic low-threshold burst neurons in the rat laterodorsal tegmental nucleus in vitro, Proc. Natl. Acad Sci. USA, 89 (1992) 743-747.
40. McCormick, D.A. and Pape, H.-C., Properties of a hyperpolarization-activated cation current and its role in rhythmic oscillations in thalamic relay neurones, J. Physiol. (Lond.). 431 (1990) 291-318.
41. McCormick, D.A., Neurotransmitter action in the thalamus and cerebral cortex and their role in neuromodulation of thalamocortical activity, Prog. Neurobiol., 39 (1992) 337-388.
42. McCormick, D.A. and Wang, Z., Serotonin and noradrenaline excite GABAergic neurons of the guinea-pig and cat reticularis thalami, J. Physiol. (Lond.), 442 (1991) 235-255.
43. 1A antagonists, J. Pharmacol. Exp. Ther., 268 (1994) 337-352.
44. 1A receptor-mediated activity in the rat: a pharmacological characterization of the actions of novel agonists and antagonists, J. Pharmacol. Exp. Ther., 264 (1993) 1364-1376.
45. 1A receptor agonist 8-OH-DPAT on sleep and wakefulness in the rat, J. Sleep Res., 1 (1992) 169-175.
46. Monti, J.M., Jantos, H., Silveira, R., Reyes-Parada, M., Scorza, C. and Prunell, G., Depletion of brain serotonin by 5,7-DHT: effects on the 8-OH-DPAT induced changes of sleep and waking in the rat, J. Sleep Res., 3 (1994) 170 (Abstract)
47. Monti, J.M., Pineyro, G., Orellana, C., Boussard, M. and Jantos, H., 5-HT receptor agonists DOI and 8-OH-DPAT increase wakefulness in the rat, Biogenic Amines, 7 (1990) 145-151.
48. Monti, J.M., Silveira, R., Reyes-Parada, M., Scorza, C. and Prunell, G., Depletion of brain serotonin by 5,7-DHT: Effects on the 8-OH-DPAT-induced changes of sleep and waking in the rat, Psychopharmacology, 115 (1994) 273-277.
49. Moret, C. and Briley, M., Serotonin autoreceptor subsensitivity and antidepressant activity, Eur. J. Pharmacol., 180 (1990) 351-356.
50. Morin, L.P., Michels, K.M., Smale, L. and Moore, R.Y., Serotonin regulation of circadian rhythmicity, Ann. NY Acad. Sci., (1990) 418-426.
51. Mühlethaler, M., Electrophysiological properties and neuromodulation of cholinergic and non-cholinergic basal forebrain neurones, J. Sleep Res., 3 (1994) 173 (Abstract)
52. Myers, R.D., Hypothalamic control of thermoregulation. In P.J. Morgane and J. Panksepp ( Eds.), Handbook of the Hypothalamus, Dekker, New York, 1980, pp. 83-210.
53. Neale, R.F., Fallon, S.L., Boyar, W.C., Wasley, J.W.F. and Martin, L. L., Biochemical and pharmacological characterization of CGS 12066B, a selective serotonin-IB agonist, Eur. J. Pharmacol., 136 (1987) 1-9.
54. Neckelmann, D., Olsen, Ø.E., Fagerland, S. and Ursin, R., The reliability and functional validity of visual and semiautomatic sleep/wake scoring in the Møll-Wistar rat, Sleep, 17 (1994) 120-131.
55. Neckelmann, D. and Ursin, R., Sleep stages and EEG power spectrum in relation to acoustical stimulus arousal threshold in the rat. Sleep, 16 (1993) 467-477.
56. Neckelmann, D. and Ursin, R., Acute and chronic citalopram differed in regional effects on NREM EEG power spectrum, J. Sleep Res., 3 (1994) 178 (Abstract)
57. Olsen, Ø.E., Neckelmann, D. and Ursin, R., Diurnal differences in 1-tryptophan sleep and temperature effects in the rat, Behav. Brain Res., 65 (1994) 195-203.
58. Portas, C.M. and McCarley, R.W., Behavioral state-related changes of extracellular serotonin consentration in the dorsal raphe nucleus: a microdialysis study in the freely moving cat, Brain Res., 648 (1994) 306-312.
59. Prosser, R.A., Dean, R.R., Edgar, D.M., Heller, H.C. and Miller, J.D., Serotonin and the mammalian circadian system: I. In vitro phase shifts by serotonergic agonists and antagonists, J. Biol. Rhythms, 8 (1993) 1-16.
60. Prosser, R.A., Miller, J.D. and Heller, H.C., A Serotonin agonist phase-shifts the circadian clock in the suprachiasmatic nuclei in vitro. Brain Res., 534 (1990) 336-339.
61. 1A receptors is responsible for the anticonflict effect of ipsapirone in rats, J. Pharm. Pharmacol., 44 (1992) 780-782.
62. Przegalinski, E., Ismaiel, A.M., Chojnacka Wojcik, E., Budziszewska, B., Tatarczynska, E. and Blaszczynska, E., The behavioural, but not the hypothermie or corticosterone, response to 8-hydroxy-2-(di-n-propylamino)tetralin, is antagonized by NAN-190 in the rat, Neuropharmacology, 29 (1990) 521-526.
63. Putkonen, P.T.S. and Leppavuori, A., Increase in paradoxical sleep in the cat after phentolamine, an alpha-adrenoceptor antagonist, Acta Physiol. Scand., 100 (1977) 488-490.
64. 1A agonist - effects of physiological and psychological variables and blood serotonin levels, Neuropsychobiology, 28 (1993) 37-42.
65. Ruigt, G.S.F., Engelen, S., Gerrits, A. and Verbon, F., Computer-based prediction of psychotropic drug classes based on a discriminant analysis of drug effects on rat sleep, Neuropsychobiology, 28 (1993) 138-153.
66. Slater, I.H., Jones, G.T. and Moore, R.A., Inhibition of REM sleep by fluoxetine, a specific inhibitor of serotonin uptake, Neuropharmacology, 17 (1978) 383-389.
67. 1A selective drugs on the 5-HT behavioral syndrome, Pharmacol. Biochem. Behav., 24 (1986) 1513-1519.
68. Sommerfelt, L., Hauge, E.R. and Ursin, R., Similar effect on REM sleep but differential effect on slow wave sleep of the two 5-HT uptake inhibitors zimeldine and alaproclate in cats and rats, J. Neural Transm., 68 (1987) 127-144.
69. Sommerfelt, L. and Ursin, R., The effects of zimeldine and alaproclate combined with a small dose of 5-HTP on waking and sleep stages in cats, Behav. Brain Res., 24 (1987) 1-10.
70. Steriade, M. and McCarley, R.W., Brainstem Control, of Wakefulness and Sleep, Plenum Press, New York, 1990.
71. Steriade, M., McCormick, D.A. and Sejnowski, T.J., Thalamocortical oscillations in the sleeping and aroused brain, Science, 262 (1993) 679-685.
72. 1A agonist, on sleep/wakefulness cycles: probable post-synaptic action, J. Sleep Res., 2(1993) 103-109.
73. Trulson, M.E. and Jacobs, B.L., Raphe unit activity in freely moving cats: correlation with level of behavioral arousal, Brain Res., 163 (1979) 135-150.
74. Ursin, R., The two stages of slow wave sleep in the cat and their relations to REM sleep, Brain Res., 11 (1968) 347-356.
75. Ursin, R., Sleep stage relations whithin the sleep cycles of the cat, Brain Res., 20 (1970) 91-97.
76. Ursin, R., Differential effect of para-chlorophenylalanine on the two slow wave sleep stages in the cat, Acta Physiol. Scand., (1972) 1-8.
77. Ursin, R., The effects of 5-hydroxytryptophan and L-tryptophan on wakefulness and sleep patterns in the cat, Brain Res., 106 (1976) 105-115.
78. Ursin, R., Bjorvatn, B., Sommerfelt, L. and Underland, G., Increased waking as well as increased synchronization following administration of selective 5-HT uptake inhibitors to rats, Behav. Brain Res., 34 (1989) 117-130.
79. Ursin, R. and Larsen. M., Increased sleep following intracerebroventricular injection of the delta sleep-inducing peptide in rats, Neurosd. Lett., 40 (1983) 145-149.
80. Van Bemmel, A.L., van den Hoofdakker, H.H., Beersma, D.G.M. and Bouhuys, A.L., Changes in sleep polygraphic variables and clinical state in depressed patients during treatment with citalopram, Psychopharmacology, 113 (1993) 225-230.
81. Wada, Y., Hasegawa, H., Nakamura, M. and Yamaguchi, N., Serotonergic Inhibition of Limbic and Thalamic Seizures in Cats, Neuropsychobiology, 25 (1992) 87-90.
82. Whitaker-Azmitia, P.M. and Peroutka, SJ., Neuropharmacology of Serotonin, New York Academy of Sciences, New York, 1990.